Matthias Van Haele

5PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 23, 2019
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.

Iván M Moya, Stéphanie A Castaldo, Laura Van den Mooter

|Feb 06, 2019
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.

Matthias Van Haele, Iván M Moya, Ruçhan Karaman

|Dec 26, 2018
High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease.

Olivier Govaere, Simon Cockell, Matthias Van Haele

Pageof 1